Merck Sharp & Dohme s.r.o.

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 3
Period: 21 August 2026 – 22 October 2026

Its main clients

Fakultní nemocnice Olomouc · 2 contracts
Fakultní nemocnice Hradec Králové · 1 contract

Where and what

Supplies · 3

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
8 December 2028 re-tender around June 2028	Léčivé přípravky s obsahem antivirotik Fakultní nemocnice Hradec Králové	PROMEDICA PRAHA GROUP, a.s. PHOENIX lékárenský velkoobchod, s.r.o. Gilead Sciences s.r.o. ROCHE s.r.o. GlaxoSmithKline, s.r.o. Merck Sharp & Dohme s.r.o. 4 bids received	–
17 August 2029 re-tender around February 2029	LP s obsahem pembrolizumabu 2026 Fakultní nemocnice Olomouc	Merck Sharp & Dohme s.r.o. 1 bid received	–
12 October 2029 re-tender around April 2029	LP s obsahem letermoviru 2026 Fakultní nemocnice Olomouc	Merck Sharp & Dohme s.r.o. 1 bid received	–

Contracts won

Date	Contract	Buyer	Amount
22/10/2026	LP s obsahem letermoviru 2026	Fakultní nemocnice Olomouc	–
01/09/2026	Léčivé přípravky s obsahem antivirotik	Fakultní nemocnice Hradec Králové	–
21/08/2026	LP s obsahem pembrolizumabu 2026	Fakultní nemocnice Olomouc	–

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.